KaydedilenlerDerginizi ekleyin

Dergiler / İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi / 2018 / Cilt: 25 - Sayı: 1

Relationship between peritoneal permeability with inflammation and subclinical atherosclerosis in peritoneal dialysis patients

Baris ESER
Ozlem YAYAR
Alper BOZKURT
Sayfa
45–50
Yayın Tarihi
2022-10-17
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

One of the causes of increased mortality rate in this group of patients may be explained by inflammation and atherosclerosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Aim: High permeability in peritoneal dialysis (PD) is reported to be associated with increased mortality.
📊
Temel Bulgular & Veri:The aim of this study is to investigate the relation of peritoneal permeability type with carotid intima media thickness (CIMT) in PD patients.Material and Methods: Based on the standard peritoneal equilibration test, 56 PD patients (28 male) were divided in two transporter groups: low (low+low average) and high (high+high average) permeability.
💡
Sonuç & Katkı:One of the causes of increased mortality rate in this group of patients may be explained by inflammation and atherosclerosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

Aim: High permeability in peritoneal dialysis (PD) is reported to be associated with increased mortality. Cardiovascular disease is the most important cause of morbidity and mortality in patients with end-stage renal disease. The inflammation is thought to take part in development of atherosclerosis. The aim of this study is to investigate the relation of peritoneal permeability type with carotid intima media thickness (CIMT) in PD patients.Material and Methods: Based on the standard peritoneal equilibration test, 56 PD patients (28 male) were divided in two transporter groups: low (low+low average) and high (high+high average) permeability. C-reactive protein (CRP) measured as a marker of inflammation and CIMT was evaluated by high-resolution B-mode ultrasonography.Results: Twenty one patients were low and 35 of them were high peritoneal transporters. Mean CRP level was significantly higher in the high permeability group (HPG) (1.62±1.7 vs 0.84±1 mg/dL; p=0.006). CIMT was higher in the HPG but this difference did not reach statistical significance (0.810±0.160 vs 0.740±0.160 mm; p=0.16).Conclusions: CRP, an indicator of inflammation, was found to be higher in the HPG. CIMT also was found to be higher in HPG although it was not statistically significant. One of the causes of increased mortality rate in this group of patients may be explained by inflammation and atherosclerosis.

🔖

Bu Makaleye Atıf Yap

ESER, B., YAYAR, O., BOZKURT, A. (2022). Relationship between peritoneal permeability with inflammation and subclinical atherosclerosis in peritoneal dialysis patients. İnönü Üniversitesi Turgut Özal Tıp Merkezi Dergisi, Cilt: 25 - Sayı: 1, 45–50. https://ajindex.com/articles/549053

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (11)

  1. Pajek J, Kveder R, Bren A, Gucek A, Ihan A, Osredkar J, et al. Short-term effects of a new bicarbonate/lactate-buffered and conventional peritoneal dialysis fluid on peritoneal and systemic inflammation in CAPD patients: a randomized controlled study. Perit Dial Int 2008;28(1):44-52.
  2. Bajo MA, Perez-Lozano ML, Albar-Vizcaino P, Del Peso G, Castro MJ, Gonzalez-Mateo G, et al. Low-GDP peritoneal dialysis fluid (‘balance’) has less impact in vitro and ex vivo on epithelial-to-mesenchymal transition (EMT) of mesothelial cells than a standard fluid. Nephrol Dial Transplant 2011;26(1):282-91.
  3. Rippe B, Simonsen O, Heimburger O, Christensson A, Haraldsson B, Stelin G, et al. Long-term clinical effects of a peritoneal dialysis fluid with less glucose degradation products. Kidney Int 2001;59(1):348-57.
  4. Wang T, Heimburger O, Cheng HH, Bergstrom J, Lindholm B. Does a high peritoneal transport rate reflect a state of chronic inflammation? Perit Dial Int 1999;19(1):17-22.
  5. Breborowicz A, Oreopoulos DG. Evidence for the presence of chronic inflammation during peritoneal dialysis: Therapeutic implications. Perit Dial Int 1997;17 suppl 2:S37-41. Kagan A, Bar Khayim Y. Role of peritoneal loss of albumin in the hypoalbuminemia of continuous ambulatory peritoneal dialysis patients: Relationship to peritoneal transport of solutes. Nephron 1995;71(3):314-20.
  6. Harty JC, Boulton H, Venning MC, Gokal R. Is peritoneal permeability an adverse risk factor for malnutrition in CAPD patients? Miner Electrolyte Metab 1996;22(1-2):97-101.
  7. Struijk DG, Krediet RT, Koomen GC, Boeschoten EW, Hoek FJ, Arisz L. A prospective study of peritoneal transport in CAPD patients. Kidney Int 1994;45(6):1739-44.
  8. Fung L, Pollock CA, Caterson RJ, Mahony JF, Waugh DA, Macadam C, et al. Dialysis adequacy and nutrition determine prognosis in continuous ambulatory peritoneal dialysis patients. J Am Soc Nephrol 1996;7(5):737-44.
  9. Han DS, Lee SW, Kang SW, Choi KH, Lee HY, Cho EY, et al. Factors affecting low values of serum albumin in CAPD patients. Adv Perit Dial 1996;12:288-92.
  10. Mutluay R, Konca C, Erten Y, Pasaoglu H, Deger SM, Agirgun C, et al. Predictive markers of asymptomatic atherosclerosis in end-stage renal disease patients. Ren Fail 2010;32(4): 448-54.
  11. Kim JK, Park S, Lee MJ, Song YR, Han SH, Kim SG, et al. Plasma levels of soluble receptor for advanced glycation end products (sRAGE) and proinflammatory ligand for RAGE (EN-RAGE) are associated with carotid atherosclerosis in patients with peritoneal dialys